News | January 31, 2022
Cipla has strong traction in India and the US: ICICI Direct
ICICI Direct’s analysis of Cipla’s Q3FY22 results
ICICI Direct’s analysis of Cipla’s Q3FY22 results
The agreement is for the development and commercialisation of JHU’s novel target and technology that will help patients with colorectal cancer
Intranasal vaccines are easier to administer in mass immunisation campaigns and help reduce or stop transmission
The new centre will comprise a team of 50 highly experienced specialists
It would be the first protein-based alternative available in Israel
The management guided for ARV API & formulation demand to be normalised from Q4FY22 and reiterated the aspiration of US $ 1 billion in sales by FY23: ICICI Direct
The aim is to strengthen industry-academia cooperation
Company to manufacture drug substance for clinical supply of HaemaLogiX’s lead multiple myeloma drug candidate, KappaMab, at its new state-of-the-art facility in Guangzhou, China
SOLOSEC is designed to be easy to take and one oral dose contains a complete course of treatment
KEYTRUDA is now approved as monotherapy for adults with Renal Cell Carcinoma (RCC)
Subscribe To Our Newsletter & Stay Updated
